| Catalog No. |
½Ã ¾à ¸í |
Æ÷Àå´ÜÀ§ |
¼øµµ |
CAS No. |
| A-1040 |
Ascomycin
ºÐÀÚ·® : 792.01 ; ºÐÀÚ½Ä : C43H69NO12
¿ëÇØµµ :Soluble in DMSO at 65 mg/mL; soluble in ethanol at 50 mg/mL with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-50 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
5mg, 25mg, 100mg, 300mg, 1g |
>99% |
[104987-12-4] |
| A-1107 |
Axitinib, Free Base
ºÐÀÚ·® : 386.47 ; ºÐÀÚ½Ä : C22H18N4OS
¿ëÇØµµ :Soluble in DMSO at 33 mg/mL; soluble in ethanol at 1.7 mg/mL with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-50 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
25mg, 50mg, 100mg, 200mg, 1g, 2g |
>98% |
|
| A-1803 |
A-7696621
À̸í :
ºÐÀÚ·® : ; 360.39 ºÐÀÚ½Ä : C20H12N2O3S
¿ëÇØµµ : Soluble in DMSO at 33 mg/mL |
10mg, 50mg, 100mg, 300mg |
>99% |
[844499-71-4] |
| A-3000 |
6"-O-Acetylgenistin
ºÐÀÚ·® : 474.41 ; ºÐÀÚ½Ä : C23H22O11
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. |
1 mg, 5mg, 10mg, 25mg |
>98% |
[73566-30-0] |
| A-6880 |
17-AAG
À̸í :Telatinib,17-(Allylamino)-17-demethoxygeldanamycin, 17-(Allylamino)geldanamycin, Tanespimycin
ºÐÀÚ·® : 585.69 ; ºÐÀÚ½Ä : C31H43N3O8
¿ëÇØµµ : Soluble in DMSO at 150 mg/mL; soluble in ethanol at 5 mg/mL; very poorly soluble in water; maximum solubility in plain water is estimated to be about 20-50 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
250mg, 1g, 2g, 5g, 10g |
>99% |
[75747-14-7] |
| A-6900 |
6"-O-Acetyldaidzin
ºÐÀÚ·® : 458.41 ; ºÐÀÚ½Ä : C23H22O10
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. |
1 mg, 5mg, 10mg, 25mg |
>98% |
[71385-83-6] |
| A-7860 |
6"-O-Acetylglycitin
ºÐÀÚ·® : 488.44 ; ºÐÀÚ½Ä : C24H24O11
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. |
1 mg, 5mg, 10mg, 25mg |
>98% |
|
| B-1080 |
Bafilomycin A1
ºÐÀÚ·® : 622.83 ; ºÐÀÚ½Ä : C35H58O9
¿ëÇØµµ :Freely soluble in DMSO; may react with methanol or ethanol, so these solvents are not recommended for stock solutions; very poorly soluble in water; maximum solubility in plain water is estimated to be about 5-10 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
1mg, 5mg, 10mg, 25mg |
>95% |
[88899-55-2] |
| B-1408 |
Bortezomib
À̸í :[Velcade] [MG-341] [PS-341]
ºÐÀÚ·® : 384.24 ; ºÐÀÚ½Ä : C19H25BN4O4
¿ëÇØµµ :Soluble in DMSO at 200 mg/mL; soluble in ethanol at 200 mg/mL; soluble in water at 3 mg/mL; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
5mg, 10mg, 25mg,50mg, 100mg, 300mg , 1g |
>99% |
[179324-69-7] |
| B-1709 |
Bosutinib, Free Base
À̸í :
ºÐÀÚ·® : 530.45; ºÐÀÚ½Ä : C26H29Cl2N5O3
¿ëÇØµµ :Soluble in DMSO at 33 mg/mL; soluble in ethanol at 10 mg/mL with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-50 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
25mg, 50mg, 100mg, 200mg, 500mg, 1g |
>99% |
[380843-75-4] |
| B-2422 |
Bexarotene, Free Acid
À̸í :[Targretin] [Targretyn] [Targrexin] [LGD-1069] [LG 1069] [LG100069] [SR-11247]
ºÐÀÚ·® : 348.48 ; ºÐÀÚ½Ä : C24H28O2
¿ëÇØµµ :Soluble in DMSO at 65 mg/mL; soluble in ethanol at 10 mg/mL with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-50 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
100mg, 300mg, 500mg, 1g, 5g |
>99% |
[153559-49-0] |
| B-3517 |
Bryostatin 2
ºÐÀÚ·® : 863.00 ; ºÐÀÚ½Ä : C45H66O16
¿ëÇØµµ :Soluble in DMSO or ethanol. |
10 ug, 25ug, 100ug |
>99% |
[87745-28-6] |
| B-6697 |
Bryostatin 1
À̸í :[B705008K112]
ºÐÀÚ·® : 458.41 ; ºÐÀÚ½Ä : C23H22O10
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. |
10ug, 25ug, 100ug, 300ug, 1 mg |
>99% |
[83314-01-6] |
| B-8500 |
Brefeldin A
ºÐÀÚ·® : 280.36 ; ºÐÀÚ½Ä : C16H24O4
¿ëÇØµµ :Soluble in DMSO or ethanol. |
10 mg, 25mg, 50mg, 100mg, 300mg, 1g |
>99% |
[20350-15-6] |
| C-1201 |
Canertinib, Dihydrochloride Salt
À̸í :[CI-1033] [PD 183805]
ºÐÀÚ·® : 558.86 ; ºÐÀÚ½Ä : C24H25ClFN5O3.2HCl
¿ëÇØµµ :Soluble in DMSO at 100 mg/mL; soluble in ethanol at 1 mg/mL with warming; soluble in water at 10 mg/mL with warming; buffers, serum, or other additives may increase or decrease the aqueous solubility. Compound is somewhat unstable in HPLC sample solution at room temperature. |
25mg, 50mg, 100mg, 200mg, 1g |
>99% |
[289499-45-2] |
| C-1502 |
Celecoxib
À̸í :[Celebrex] [Celebra] [Celecox] [Onsenal] [Solexa] [SC-58635] [YM-177]
ºÐÀÚ·® : 381.37 ; ºÐÀÚ½Ä : C17H14F3N3O2S
¿ëÇØµµ : Soluble in DMSO at 200 mg/mL; soluble in ethanol at 100 mg/mL; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-50 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
300mg, 1g, 5g, 25g, 100g |
>99% |
[169590-42-5] |
| C-2606 |
CI-994, Free Base
À̸í :[Tacedinaline] [Acetyldinaline] [Goe-5549] [Go 5549] [PD 123654]
ºÐÀÚ·® : ; ºÐÀÚ½Ä :
¿ëÇØµµ : Soluble in water (5 mg/ml) or DMSO (>10 mg/ml). |
50mg, 100mg, 300mg, 1g, 5g |
>99% |
|
| C-2799 |
Capecitabine
À̸í :[Xeloda] [Ro-9-1978] [Caxeta] [Capecitabin] [Capiibine]
ºÐÀÚ·® : ; ºÐÀÚ½Ä :
¿ëÇØµµ : |
500mg, 1g, 2g, 5g, 25g |
>99% |
|
| C-3030 |
Chelerythrine Chloride
ºÐÀÚ·® : 383.82 ; ºÐÀÚ½Ä : C21H18NO4Cl
¿ëÇØµµ : Soluble in water (5 mg/ml) or DMSO (>10 mg/ml). |
5mg, 10mg, 25mg, 100mg |
>99% |
[3895-92-9] |
| C-3987 |
Calyculin A
ºÐÀÚ·® : 1009.17 ; ºÐÀÚ½Ä : C50H81N4O15P
¿ëÇØµµ :Soluble in DMSO and ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 1-10 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility .
ÁÖÀÇ:TUMOR PROMOTER. Gloves and mask should be worn when using this compound. Care must be taken to prevent contact through all routes of exposure |
50ug, 100ug, 300ug, 1mg |
>98% |
[101932-71-2] |
| C-6000 |
Cyclosporin A
À̸í :[Cyclosporine] [Antibiotic S 7481F1] [Ciclosporin A] [Ramihyphin A] [CsA]
ºÐÀÚ·® : 1202.61 ; ºÐÀÚ½Ä : C62H111N11O12
¿ëÇØµµ : Soluble in DMSO or ethanol; (1 mL of ethanol will dissolve 160 mg). |
1g, 5g, 10g, 25g, 100g |
>99% |
[59865-13-3] |
| C-8700 |
Cyclopamine, Free Base
À̸í :[11-Deoxyjervine]
ºÐÀÚ·® : 411.62 ; ºÐÀÚ½Ä : C27H41NO2
¿ëÇØµµ : Soluble in DMSO(4mg/ml), methanol (7mg/ml) or 2% ethanol (20mg/ml).
ÁÖÀÇ:TERATOGEN. Gloves and mask should be worn when using this compound. Care must be taken to prevent contact through all routes of exposure. Women of childbearing age should be extremely careful in handling cyclopamine! |
25mg, 50mg, 100mg, 300mg, 500mg, 1g, 2g |
>99% |
[4449-51-8] |
| D-1000 |
Docetaxel
À̸í :[Taxotere] [RP 56976]
ºÐÀÚ·® : 807.88 ; ºÐÀÚ½Ä : C43H53NO14
¿ëÇØµµ :Soluble in DMSO (up to about 200 mg/mL) or ethanol (up to about 100 mg/mL). |
100mg, 500mg, 1g, 2, 5g, 10g |
>99% |
[114977-28-5] |
| D-2744 |
Doramapimod, Free Base
À̸í :[BIRB 796]
ºÐÀÚ·® : 527.66 ; ºÐÀÚ½Ä : C31H37N5O3
¿ëÇØµµ :Soluble in DMSO. |
5mg, 25mg, 100mg |
>98% |
[285983-48-4] |
| D-2946 |
Daidzein
À̸í :[4',7-Dihydroxyisoflavone] [7-Hydroxy-3-(4-hydroxyphenyl)chromone]
ºÐÀÚ·® : 254.24 ; ºÐÀÚ½Ä : C15H10O4
¿ëÇØµµ : Soluble in DMSO; very poorly soluble in other solvents. |
1g, 5g, 10g, 25g, 100g |
>99% |
[486-66-8] |
| D-3307 |
Dasatinib, Free Base
À̸í :[BMS-354825] [Sprycel]
ºÐÀÚ·® : 488.01 ; ºÐÀÚ½Ä : C22H26ClN7O2S
¿ëÇØµµ : Soluble in DMSO at 200 mg/mL; very poorly soluble in ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
500mg, 1g, 2g, 5g, 10g, 25g |
>99% |
[302962-49-8] |
| D-3440 |
17-DMAG, Hydrochloride Salt
ºÐÀÚ·® : 653.21 ; ºÐÀÚ½Ä : C32H48N4O8.HCl
¿ëÇØµµ :Soluble in DMSO; soluble up to about 2 mg/mL in water. |
250mg, 1g, 2g, 5g, 10g, |
>99% |
[150270-08-9] |
| D-3608 |
Dovitinib, Free Base
À̸í :[CHIR-258] [TKI-258]
ºÐÀÚ·® : 392.43 ; ºÐÀÚ½Ä : C21H21FN6O
¿ëÇØµµ :Soluble in DMSO. |
10mg, 25mg, 50mg, 100mg, 200mg, 500mg, 1g |
>99% |
[405169-16-6] |
| D-4000 |
Doxorubicin, Hydrochloride Salt
À̸í :[Adriacin] [Adriamycin] [Adriblastin] [Adriblastina] [Caelyx] [Dox] [Doxil] [Farmiblastina] [FI-106] [14-Hydroxydaunomycin] [Lipodox] [Myocet] [Rubex]
ºÐÀÚ·® : 579.98 ; ºÐÀÚ½Ä : C27H29NO11.HCl
¿ëÇØµµ :Soluble in DMSO. |
100mg, 250mg, 1g, 2g |
>99% |
[25316-40-9] |
| D-7878 |
Daidzin
À̸í :[4',7-Dihydroxyisoflavone, 7-O-¥â-D-glucopyranoside] [Daidzein, 7-O-¥â-D-glucopyranoside]
ºÐÀÚ·® : 416.38 ; ºÐÀÚ½Ä : C21H20O9
¿ëÇØµµ : Soluble in DMSO. |
25mg, 100mg, 300mg, 1g |
>99% |
[552-66-9] |
| D-9200 |
(R,S)-2,3-Dihydrodaidzein
ºÐÀÚ·® : 256.25 ; ºÐÀÚ½Ä : C15H12O40
¿ëÇØµµ :Soluble in DMSO, methanol, or ethanol. |
50mg, 100mg, 500mg |
>99% |
|
| E-3866 |
Entinostat, Free Base
À̸í :[4',7-Isoflavandiol]
ºÐÀÚ·® : ; ºÐÀÚ½Ä :
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. |
25mg, 50mg, 100mg, 200mg, 1g, 2g |
>99% |
|
| E-4007 |
Erlotinib, Hydrochloride Salt
ºÐÀÚ·® : 429.90 ; ºÐÀÚ½Ä : C22H23N3O4.HCl
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. |
1g, 2g, 5g, 10g, 25g, 100g |
>99% |
[183319-69-9] |
| E-4040 |
Everolimus
À̸í :[SDZ-RAD] [Certican] [RAD001]
ºÐÀÚ·® : 958.22 ; ºÐÀÚ½Ä : C53H83NO14
¿ëÇØµµ :Soluble in DMSO at 100 mg/mL; soluble in ethanol at 100 mg/mL; very poorly soluble in water; maximum solubility in plain water is estimated to be about 1-10 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
5mg, 25mg, 100mg, 300mg |
>99% |
[159351-69-6] |
| E-4506 |
Enzastaurin, Free Base
À̸í :
ºÐÀÚ·® : ; ºÐÀÚ½Ä :
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. |
100mg, 500mg, 1g, 5g, 10g |
>99% |
|
| E-5500 |
Epothilone B, Free Base 
À̸í :[EPO-906] [EpoB] [Patupilone]
ºÐÀÚ·® : 507.68 ; ºÐÀÚ½Ä : C27H41NO6S
¿ëÇØµµ :Soluble in DMSO |
1mg, 5mg, 10mg, 25mg |
>99% |
[152044-54-7] |
| E-5880 |
(R,S)-Equol
À̸í :[4',7-Isoflavandiol]
ºÐÀÚ·® : 242.27 ; ºÐÀÚ½Ä : C15H14O3
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. |
100mg, 500mg, 1g, 5g, 10g |
>99% |
[531-95-3] |
| F-4660 |
Fasudil, Monohydrochloride Salt
ºÐÀÚ·® : 327.83 ; ºÐÀÚ½Ä : C14H17N3O2S.HCl0
¿ëÇØµµ :Very soluble in water, up to about 200 mg/mL ; soluble in DMSO up to about 95 mg/mL; not soluble in ethanol; addition of an aqueous solution of this monohydrochloride salt into a buffer solution may significantly alter its solubility. |
250mg, 500mg, 1g, 2g, 5g, 10g |
>99% |
[105628-07-7] |
| F-4633 |
Fingolimod, Hydrochloride Salt
À̸í :[FTY-720A] [FTY720]
ºÐÀÚ·® : 343.938 ; ºÐÀÚ½Ä : C19H33NO2?HCl
¿ëÇØµµ :Soluble in DMSO . |
50mg, 100mg, 200mg, 300mg,1g, 2g, 5g, 10g |
>98% |
[162359-56-0] |
| F-4900 |
FK-506
À̸í :[Tacrolimus] [Fujimycin] [Prograf]
ºÐÀÚ·® : 804.02 ; ºÐÀÚ½Ä : C44H69NO12
¿ëÇØµµ :Soluble in DMSO at 100 mg/mL; soluble in ethanol at 100 mg/mL; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
50mg, 100mg, 200mg, 500mg, 1g, 2g, 5g |
>98% |
[104987-11-3] |
| F-9929 |
Forskolin
ºÐÀÚ·® : 410.50 ; ºÐÀÚ½Ä : C22H34O7
¿ëÇØµµ :Soluble in DMSO (5 mg/ml) or ethanol (6 mg/ml). |
50mg, 100mg, 300mg, 1g, 3 g |
>99% |
[66575-29-9] |
| G-1152 |
Glycitein
À̸í :[4',7-Dihydroxy-6-methoxyisoflavone]
ºÐÀÚ·® : 284.26 ; ºÐÀÚ½Ä : C16H12O5
¿ëÇØµµ :Very insoluble (less than 100 ¥ìg/ml) in methanol, ethanol, or water; soluble in DMSO. |
5mg, 10mg, 25mg, 100mg |
>99% |
[40957-83-3] |
| G-2822 |
Glycitin
À̸í :[Glycitein, 7-O-¥â-D-glucopyranoside]
ºÐÀÚ·® : 446.40 ; ºÐÀÚ½Ä : C22H22O10
¿ëÇØµµ :Soluble in DMSO poorly; insoluble in other solvents. |
5mg, 10mg, 25mg, 100mg |
>99% |
[40246-10-4] |
| G-4177 |
Gemcitabine, Hydrochloride Salt
À̸í :[dFdC] [Gamcitabine] [Gemcitera] [Gemsar] [Gemzar] [LY-188011]
ºÐÀÚ·® : ; 299.66 ºÐÀÚ½Ä : C9H11F2N3O4?HCl
¿ëÇØµµ : Soluble in DMSO at 12.5 mg/mL with slight warming; very poorly soluble in ethanol; soluble in water at 25 mg/mL with slight warming; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
100mg, 300mg, 500mg, 1g, 2g, 5g |
>99% |
[122111-03-9] |
| G-4408 |
Gefitinib, Free Base
À̸í :[ZD-1839] [Iressa]
ºÐÀÚ·® : 446.90 ; ºÐÀÚ½Ä : C22H24ClFN4O3
¿ëÇØµµ :Soluble in DMSO, up to about 100 mg/mL; very poorly soluble in water or ethanol. |
1g, 2g, 5g, 10g, 25g, 100g |
>99% |
[184475-35-2] |
| G-4500 |
Geldanamycin
À̸í :[Geldanomycin] [U-29135]
ºÐÀÚ·® : 560.64 ; ºÐÀÚ½Ä : C29H40N2O9
¿ëÇØµµ :Soluble in DMSO at 100 mg/mL; see further information below for stability and solubility in other solvents. |
250mg, 1g, 2g, 5g, 10g, 25g |
>99% |
[30562-34-6] |
| G-5200 |
Genistin
À̸í :[Genistein, 7-O-¥â-D-glucopyranoside]
ºÐÀÚ·® : 432.384 ; ºÐÀÚ½Ä : C21H20O10
¿ëÇØµµ :Soluble in DMSO. |
25mg, 100mg, 300mg, 1g |
>99% |
[529-59-9] |
| G-5903 |
GW2580, Free Base
À̸í :[cFMS Receptor Tyrosine Kinase Inhibitor] [CSF-1 Receptor Inhibitor]
ºÐÀÚ·® : ; 366.41 ºÐÀÚ½Ä : C20H22N4O3
¿ëÇØµµ : Soluble in DMSO at 40 mg/mL; very poorly soluble in ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 20-100 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
100mg, 300mg, 1g, 5g |
>99% |
[870483-87-7] |
| G-6055 |
Genistein
À̸í :[4',5,7-Trihydroxyisoflavone]
ºÐÀÚ·® : 270.24 ; ºÐÀÚ½Ä : C15H10O5
¿ëÇØµµ :Soluble in DMSO. |
1g, 10g, 25g, 100g |
>99% |
[446-72-0] |
| G-6203 |
Go 6976
À̸í :[PD 406976] [Go 6976]
ºÐÀÚ·® : 378.43 ; ºÐÀÚ½Ä : C24H18N4O0
¿ëÇØµµ :Soluble in DMSO. |
1 mg, 5mg, 10mg, 25mg |
>99% |
[136194-77-9] |
| G-9252 |
GDC-0941, Free Base
À̸í :
ºÐÀÚ·® : 513.64 ; ºÐÀÚ½Ä : C23H27N7O3S2
¿ëÇØµµ :Soluble in DMSO |
5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 500mg, 1g |
>99% |
[957054-30-7] |
| H-2330 |
HA-1077, Dihydrochloride Salt,
À̸í :[Fasudil, Dihydrochloride Salt] [1-(5-Isoquinolinesulfonyl)homopiperazine, Dihydrochloride Salt] [Eril] [AT-877]
ºÐÀÚ·® : 364.29 ; ºÐÀÚ½Ä : C14H17N3O2S.2HCl
¿ëÇØµµ :Very soluble in water, up to 200 mg/mL or more; soluble in DMSO up to about 10 mg/mL; not soluble in ethanol; addition of an aqueous solution of this dihydrochloride salt into a buffer solution may significantly alter its solubility. |
250mg, 500mg, 1g, 2g,5g, 10g |
>99% |
[103745-39-7] |
| H-5239 |
H-89, Dihydrochloride Salt
À̸í :[N-[2-(p-Bromocinnamylamino)ethyl]-5-isoquinoline sulfonamide, Di-HCl Salt]
ºÐÀÚ·® : 519.28 ; ºÐÀÚ½Ä : C20H20BrN3O2S.2HCl
¿ëÇØµµ :Soluble in DMSO, water (up to 25 mg/mL; heat to dissolve), or ethanol/water. |
10 mg, 25mg, 100mg, 300mg |
>99% |
[127243-85-0] |
| I-1711 |
(-)-Indolactam V
ºÐÀÚ·® : 301.38 ; ºÐÀÚ½Ä : C17H23N3O2
¿ëÇØµµ :Soluble in DMSO or ethanol.ÁÖÀÇ:Weak tumor promoter. Gloves and mask should be worn when using this compound. Care must be taken to avoid contact via all routes of exposure. |
300ug, 1mg, 5mg |
>99% |
[90365-57-4] |
| I-4122 |
Irinotecan, Hydrochloride Salt, Trihydrate
À̸í :[Camptosar] [Topotecin] [Campto] [Camptothecin 11] [CPT-11] [U-101440E] [DQ-2805]
ºÐÀÚ·® :677.18 ; ºÐÀÚ½Ä : C33H38N4O6.HCl.3H2O
¿ëÇØµµ :Soluble in DMSO at 100 mg/mL; very poorly soluble in ethanol; soluble in water at 25 mg/mL; buffers, serum, or other additives may increase or decrease the aqueous solubility.> |
100mg, 250mg, 1g, 2g |
>99% |
[136572-09-3] |
| I-5508 |
Imatinib, Methanesulfonate Salt
À̸í :[Imatinib Mesylate] [Gleevec] [Glivec] [CGP-57148B] [STI-571]
ºÐÀÚ·® : 589.71 ; ºÐÀÚ½Ä : C29H31N7O.CH4SO3
¿ëÇØµµ :Soluble in DMSO at 100 mg/mL; very poorly soluble in ethanol; soluble in water at 200 mg/mL; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
500mg, 1g, 2g, 5g, 10g, 25g |
>99% |
[220127-57-1] |
| I-5700 |
Ionomycin, Free Acid
ºÐÀÚ·® :709.00 ; ºÐÀÚ½Ä : C41H72O9
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. ÁÖÀÇ:Toxic. |
1 mg, 5mg, 10mg, 25mg |
>99% |
[56092-81-0] |
| I-5900 |
Ingenol 3-Angelate
À̸í :[PEP005] [3-Ingenyl Angelate] [Ingenyl 3-Angelate] [3-Angeloyl Ingenol] [3-Angelyl Ingenol]
ºÐÀÚ·® : 430.53 ; ºÐÀÚ½Ä : C23H22O10
¿ëÇØµµ :Soluble in DMSO or ethanol.
ÁÖÀÇ:TUMOR PROMOTER. Gloves and mask should be worn when using this compound. Care must be taken to prevent contact through all routes of exposure |
1 mg, 5 mg |
>99% |
|
| I-6800 |
Ionomycin, Calcium Salt
ºÐÀÚ·® : 747.07 ; ºÐÀÚ½Ä : C41H70O9.Ca
¿ëÇØµµ :Soluble in DMSO. ÁÖÀÇ:Toxic. |
5mg, 10mg, 25mg, 100mg |
>99% |
[56092-82-1] |
| I-8560 |
Ingenol
ºÐÀÚ·® : 348.43 ; ºÐÀÚ½Ä : C20H28O5
¿ëÇØµµ :Soluble in DMSO or ethanol. |
1 mg, 5mg |
>99% |
[30220-46-3] |
| K-2151 |
K-252a
À̸í : [K252a]
ºÐÀÚ·® : 467.47 ; ºÐÀÚ½Ä : C27H21N3O5
¿ëÇØµµ :Soluble in DMSO at 100 mg/mL; poorly soluble in ethanol. |
1 mg, 5mg, 25mg |
>99% |
[97161-97-2] |
| K-9609 |
K-252c
À̸í : [Staurosporine Aglycone] [Staurosporinone] [K252c] [K 252c]
ºÐÀÚ·® : 311.34 ; ºÐÀÚ½Ä : C20H13N3O
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. |
1 mg, 5mg, 10mg, 25mg |
>99% |
[85753-43-1] |
| L-4804 |
Lapatinib, Di-p-Toluenesulfonate Salt,
À̸í : [Lapatinib Ditosylate] [Tykerb] [GW-572016] [Tyverb]
ºÐÀÚ·® : 925.46 ; ºÐÀÚ½Ä : C29H26ClFN4O4S.2C7H8O3S
¿ëÇØµµ :Soluble in DMSO at 200 mg/mL; very poorly soluble in ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 1-10 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
100mg, 200mg, 300mg, 500mg, 1g, 2g, 5g, 10g, 25g |
>99% |
[388082-78-8] |
| L-4899 |
Lapatinib, Free Base
À̸í :[dFdC] [Gamcitabine] [Gemcitera] [Gemsar] [Gemzar] [LY-188011]
ºÐÀÚ·® : ; 581.06 ºÐÀÚ½Ä : C29H26ClFN4O4S
¿ëÇØµµ : Soluble in DMSO at 200 mg/mL; very poorly soluble in ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 1-10 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
100mg, 200mg, 300mg, 500mg, 1g, 2g, 5g, 10g, 25g |
>99% |
[231277-92-2] |
| L-5499 |
(R,S)-Lenalidomide, Free Base
À̸í :[CC-5013] [CDC-501] [ENMD-0997] [Revamid] [Revimid] [Revlimid]
ºÐÀÚ·® : ; 259.26 ºÐÀÚ½Ä : C13H13N3O3
¿ëÇØµµ : Soluble in DMSO at 100 mg/mL; very poorly soluble in ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 20-100 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility |
200mg, 500mg, 1g, 2g, 5g, 10g |
>99% |
[191732-72-6] |
| L-6100 |
Leptomycin B, Free Acid
À̸í : [LMB] [Elactocin] [Mantuamycin] [CI-940] [CL-1957A] [PD-114720] [ATS 1287B]
ºÐÀÚ·® : 540.73 ; ºÐÀÚ½Ä : C33H48O6
¿ëÇØµµ :Soluble in methanol or ethanol. |
100ug, 500ug, 1mg |
>99% |
[87081-35-4] |
| L-6307 |
Lestaurtinib
À̸í : [CEP-701] [KT-5555]
ºÐÀÚ·® : 439.46 ; ºÐÀÚ½Ä : C26H21N3O4
¿ëÇØµµ :Soluble in DMSO at 100 mg/mL; soluble in ethanol at 20 mg/mL; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
1 mg, 5mg, 25mg, 100mg, 300mg |
>99% |
[111358-88-4] |
| L-7962 |
LY 294002
À̸í : [2-(4-Morpholino)-8-phenyl-4H-1-benzopyran-4-one]
ºÐÀÚ·® : 307.34 ; ºÐÀÚ½Ä : C19H17NO3
¿ëÇØµµ :Soluble in DMSO or ethanol. |
5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 300mg |
>99% |
[154447-36-6] |
| M-2433 |
Mocetinostat, Free Base
À̸í : [MG-0103] [MGCD0103]
ºÐÀÚ·® : 396.44 ; ºÐÀÚ½Ä : C23H20N6O
¿ëÇØµµ : Soluble in DMSO. |
10mg, 50mg, 200mg 1g |
>99% |
[726169-73-9] |
| M-4620 |
6"-O-Malonylglycitin, Free Acid
ºÐÀÚ·® : 532.45 ; ºÐÀÚ½Ä : C25H24O13
¿ëÇØµµ :Soluble in DMSO, methanol, ethanol, or mixtures of acetonitrile/water. |
1 mg, 5mg, 10mg, 25mg |
>98% |
|
| M-5602 |
Mubritinib, Free Base
À̸í : [TAK-165]
ºÐÀÚ·® : 468.473 ; ºÐÀÚ½Ä : C25H23F3N4O2
¿ëÇØµµ : Soluble in DMSO. |
10mg, 25mg, 50mg, 100mg, 200mg 500mg |
>99% |
[366017-09-6] |
| M-6730 |
6"-O-Malonyldaidzin, Free Acid
ºÐÀÚ·® : 502.42 ; ºÐÀÚ½Ä : C24H22O12
¿ëÇØµµ :Soluble in DMSO, methanol, ethanol, or mixtures of acetonitrile/water. |
1 mg, 5mg, 10mg, 25mg |
>98% |
|
| M-7007 |
Masitinib, Free Base
À̸í : [AB-1010] [Masatinib] 8
ºÐÀÚ·® : 498.648; ºÐÀÚ½Ä : C28H30N6OS
¿ëÇØµµ :Soluble in DMSO. |
25mg, 50mg, 100mg, 200mg, 1g |
>99% |
[790299-79-5] |
| M-8090 |
6"-O-Malonylgenistin, Free Acid
ºÐÀÚ·® : 518.42 ; ºÐÀÚ½Ä : C24H22O13
¿ëÇØµµ :Soluble in DMSO, methanol, ethanol, or mixtures of acetonitrile/water. |
1 mg, 5mg, 10mg, 25mg |
>98% |
|
| N-4288 |
NVP-BEZ235, Free Base
À̸í : [BEZ235]
ºÐÀÚ·® : 469.54 ; ºÐÀÚ½Ä : C30H23N5O
¿ëÇØµµ :Soluble in DMSO. |
10mg, 25mg, 50mg, 100mg, 200mg,500mg, 1 g, 2g |
>99% |
[915019-65-7] |
| N-8207 |
Nilotinib, Free Base
À̸í : [AMN-107] [Tasigna]
ºÐÀÚ·® : 529.52 ; ºÐÀÚ½Ä : C28H22F3N7O
¿ëÇØµµ :Soluble in DMSO, up to about 50 mg/mL; not soluble in ethanol or water. |
25mg, 100mg, 300mg, 500mg, 1g, 2g, 5g |
>99% |
[641571-10-0] |
| O-2220 |
Okadaic Acid, Free Acid
À̸í : [Halochondrine A]
ºÐÀÚ·® : 805.00 ; ºÐÀÚ½Ä : C44H68O13
¿ëÇØµµ :Soluble in DMSO or ethanol. ÁÖÀÇ:Highly irritant to skin and mucous membranes. SPECIAL HAZARD: TUMOR PROMOTER. Gloves and mask should be worn when using this compound. Care must be taken to prevent contact through all routes of exposure. |
50ug, 100ug, 300ug, 1mg, 2mg, 5mg |
>99% |
[78111-17-8] |
| O-5679 |
OSU-03012, Hydrochloride Salt
À̸í : [OSU03012]
ºÐÀÚ·® : 496.91 ; ºÐÀÚ½Ä : C26H19F3N4O.HCl
¿ëÇØµµ :Soluble in DMSO. |
5mg, 25mg, 100mg |
>98% |
[742112-33-0] |
| O-5857 |
Okadaic Acid, Sodium Salt
À̸í : [Halochondrine A, Sodium Salt]
ºÐÀÚ·® : 826.98 ; ºÐÀÚ½Ä : C44H67O13.Na
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. ÁÖÀÇ:Highly irritant to skin and mucous membranes. SPECIAL HAZARD: TUMOR PROMOTER. Gloves and mask should be worn when using this compound. Care must be taken to prevent contact through all routes of exposure. |
50ug, 100ug, 300ug, 1mg, 2mg, 5mg |
>98% |
[209266-80-8] |
| O-6410 |
Okadaic Acid, Ammonium Salt
À̸í : [Halochondrine A, Ammonium Salt]
ºÐÀÚ·® : 822.03 ; ºÐÀÚ½Ä : C44H67O13.NH4
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. ÁÖÀÇ:Highly irritant to skin and mucous membranes. SPECIAL HAZARD: TUMOR PROMOTER. Gloves and mask should be worn when using this compound. Care must be taken to prevent contact through all routes of exposure. |
50ug, 100ug, 300ug, 1mg, 2mg, 5mg |
>98% |
[155716-06-6] |
| O-7111 |
Oxaliplatin
À̸í : [Foloxatine] [Transplatin] [Eloxatin] [Eloxatine] [Elplat] [RP 54780] [Dacplat] [Oxalato(1R,2R-cyclohexanediamine)platinum(II)] [Oxalatoplatin] [Oxalatoplatinum]
ºÐÀÚ·® : 397.29 ; ºÐÀÚ½Ä : C8H14N2O4Pt
¿ëÇØµµ :Soluble in water at 4 mg/mL and DMSO at 20 mg/mL; very slightly soluble in methanol; insoluble in ethanol. |
300mg, 1g, 2g |
>99% |
[61825-94-3][63121-00-6] |
| O-7519 |
Okadaic Acid, Potassium Salt
À̸í : [Halochondrine A, Potassium Salt]
ºÐÀÚ·® : 843.09 ; ºÐÀÚ½Ä : C44H67O13.K
¿ëÇØµµ :Soluble in DMSO or ethanol. ÁÖÀÇ:Highly irritant to skin and mucous membranes. SPECIAL HAZARD: TUMOR PROMOTER. Gloves and mask should be worn when using this compound. Care must be taken to prevent contact through all routes of exposure. |
50ug, 100ug, 300ug, 1mg, 2mg, 5mg |
>98% |
[155751-72-7] |
| O-9201 |
Olaparib 
À̸í :[AZD-2281] [KU-59436]
ºÐÀÚ·® : 434.46 ; ºÐÀÚ½Ä : C24H23FN4O3
¿ëÇØµµ : Soluble in DMSO. |
5mg, 10mg, 25mg, 50mg, 100mg,200mg, 250mg, 1g |
>99% |
[763113-22-0] |
| P-1010 |
Phorbol
ºÐÀÚ·® : 364.43 ; ºÐÀÚ½Ä : C20H28O6
¿ëÇØµµ :Soluble in DMSO or ethanol. |
>1 mg, 5mg |
>99% |
[17673-25-5] |
| P-1680 |
Phorbol 12-Myristate 13-Acetate
À̸í : [PMA] [TPA] [Cocarcinogen A1] [12-O-Tetradecanoyl-phorbol 13-Acetate]
ºÐÀÚ·® : 616.83; ºÐÀÚ½Ä : C36H56O8
¿ëÇØµµ :Soluble in DMSO or ethanol. ÁÖÀÇ:Highly irritant to skin and mucous membranes. SPECIAL HAZARD: TUMOR PROMOTER. Gloves and mask should be worn when using this compound. Care must be taken to prevent contact through all routes of exposure. |
1 mg, 5mg, 10mg, 25mg , 100mg |
>99.5% |
[16561-29-8] |
| P-2170 |
4¥á-Phorbol 12,13-Didecanoate
À̸í : [4¥á-PDD]
ºÐÀÚ·® : 672.93; ºÐÀÚ½Ä : C40H64O8
¿ëÇØµµ :Soluble in DMSO or ethanol. |
1 mg, 5mg, 10mg, 25mg |
>99% |
[27536-56-7] |
| P-3703 |
Panobinostat, Free Base
À̸í :[Faridak] [LBH-589] [NVP-LBH-589]
ºÐÀÚ·® : ; 349.43 ºÐÀÚ½Ä : C21H23N3O2
¿ëÇØµµ : Soluble in DMSO. |
5mg, 25mg, 50mg, 100mg, 300mg, 1g |
>99% |
[404950-80-7] |
| P-4313 |
PD 98059
À̸í : [2'-Amino-3'-methoxyflavone] [PD98059] [PD-98059]
ºÐÀÚ·® : 267.28; ºÐÀÚ½Ä : C16H13NO3
¿ëÇØµµ : Soluble in DMSO. |
5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 300mg, 1g |
>99% |
[167869-21-8] |
| P-4462 |
Prostratin
À̸í : [12-Deoxyphorbol 13-Acetate] [dPAc]
ºÐÀÚ·® : 390.47 ; ºÐÀÚ½Ä : C22H30O6
¿ëÇØµµ :Soluble in DMSO or ethanol. |
1 mg, 5mg, 25mg |
>99% |
[60857-08-1] |
| P-4833 |
Phorbol 12,13-Dibutyrate
À̸í : [PDBu]
ºÐÀÚ·® : 504.61 ; ºÐÀÚ½Ä : C28H40O8
¿ëÇØµµ :Soluble in DMSO or ethanol. ÁÖÀÇ:Highly irritant to skin and mucous membranes. SPECIAL HAZARD: TUMOR PROMOTER. Gloves and mask should be worn when using this compound. Care must be taken to prevent contact through all routes of exposure. |
1 mg, 5mg, 10mg |
>99% |
[37558-16-0] |
| P-6040 |
Pimecrolimus
À̸í : [Elidel] [SDZ-ASM-981]
ºÐÀÚ·® : 810.45 ; ºÐÀÚ½Ä : C43H68ClNO11
¿ëÇØµµ :Soluble in DMSO and ethanol, up to about 25 mg/mL. |
5mg, 10mg,25mg, 50mg, 100mg, 200mg, 300mg, |
>99% |
[137071-32-0] |
| P-6706 |
Pazopanib, Free base
À̸í : [GW-786034] [Armala]
ºÐÀÚ·® : 437.52 ºÐÀÚ½Ä : C21H23N7O2S
CAS No. :[444731-52-6]
¿ëÇØµµ :Soluble in DMSO |
10mg, 25mg, 50mg, 100mg, 200mg, 500mg, 1g |
>99.0% |
|
| P-7050 |
PIK-75, Hydrochloride Salt 
À̸í : [PI3-Kinase ¥á Inhibitor VIII]
ºÐÀÚ·® : ; 488.74ºÐÀÚ½Ä : C16H14BrN5O4S.HCl
¿ëÇØµµ : Soluble in DMSO. |
25mg, 50mg, 100mg, 200mg, 1g |
>99% |
[372196-67-3] |
| P-7177 |
Pemetrexed, Disodium Salt, Heptahydrate
À̸í : [Alimta] [LY-231514] [MTA] [Rolazar] [Tifolar]
ºÐÀÚ·® : ; 597.48ºÐÀÚ½Ä : C20H19N5Na2O6?7H2O
¿ëÇØµµ : Very poorly soluble in DMSO; very poorly soluble in ethanol; soluble in water at 100 mg/mL; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
250mg, 500mg, 1g, 2g, 5g, 10g |
>99% |
[357166-29-1] |
| P-7501 |
PX-866
À̸í :[DJM-166] [DJM-2-166]
ºÐÀÚ·® : ; 525.59 ºÐÀÚ½Ä : C29H35NO8
¿ëÇØµµ : Soluble in DMSO |
5mg, 10mg, 25mg, 100mg, 300mg |
>99% |
[502632-66-8] |
| P-7600 |
PKC412
À̸í : [CGP41251] [4'-N-Benzoyl Staurosporine] [Midostaurin]
ºÐÀÚ·® : 570.64; ºÐÀÚ½Ä : C35H30N4O4
¿ëÇØµµ :Soluble in DMSO. |
1 mg, 5mg, 10mg, 25mg, 100mg |
>99% |
[120685-11-2] |
| P-8499 |
PD 184352, Free Base 
À̸í :[CI-1040]
ºÐÀÚ·® : ; 478.66 ºÐÀÚ½Ä : C17H14ClF2IN2O2
¿ëÇØµµ : Soluble in DMSO. |
5mg, 10mg, 25mg, 50mg, 100mg, 200mg , 500mg, 1g |
>99% |
[212631-79-3] |
| P-8880 |
4¥á-Phorbol 12-Myristate 13-Acetate
À̸í : [4¥á-PMA] [4¥á-TPA] [4¥á-12-O-Tetradecanoylphorbol 13-Acetate]
ºÐÀÚ·® : 616.83 ; ºÐÀÚ½Ä : C36H56O8
¿ëÇØµµ :Soluble in DMSO or ethanol. |
1 mg, 5mg, 10mg, 25mg |
>99% |
[63597-44-4] |
| P-9050 |
PIK-90, Free Base 
À̸í :
ºÐÀÚ·® : ; 351.36 ºÐÀÚ½Ä : C18H17N5O3
¿ëÇØµµ : Soluble in DMSO. |
10mg, 50mg, 100mg, 200mg,1g |
>99% |
[677338-12-4] |
| P-9600 |
Paclitaxel
À̸í : [Taxol]
ºÐÀÚ·® : 853.91; ºÐÀÚ½Ä : C47H51NO14
¿ëÇØµµ :Soluble in DMSO (up to about 200 mg/mL) or ethanol (up to about 40 mg/mL). |
100mg, 500mg, 1g, 2g, 5g, 10g |
>99.5% |
[33069-62-4] |
| P-9688 |
PD 325901, Free Base
À̸í :[MEK1/2 Inhibitor III] [PD0325901]
ºÐÀÚ·® : ; 482.19 ºÐÀÚ½Ä : C16H14F3IN2O4
¿ëÇØµµ : Soluble in DMSO. |
5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 500mg, 1g |
>99% |
[391210-10-9] |
| R-1234 |
Roscovitine, Free Base
À̸í : [CYC202] [Seliciclib] [6-Benzylamino-2[(R)-(1'-ethyl-2'-hydroxyethylamino)]-9-isopropylpurine]
ºÐÀÚ·® : 354.45 ; ºÐÀÚ½Ä : C19H26N6O
¿ëÇØµµ :Prepare initial stock solutions in DMSO (soluble at 200 mg/mL) or ethanol (soluble at 200 mg/mL) for in vitro use; solubility in water is low. |
5mg, 10mg, 25mg, 100mg, 200mg, 300mg, 1g |
>99% |
[186692-46-6] |
| R-5000 |
Rapamycin
À̸í : [RAPA] [Rapamune] [Sirolimus] [AY-22989] [LCP-Siro] [SILA 9268A]
ºÐÀÚ·® : 914.17 ; ºÐÀÚ½Ä : C51H79NO13
¿ëÇØµµ :Soluble in DMSO, methanol or ethanol. |
50mg, 100mg, 200mg, 300mg, 500mg, 1g, 2g, 5g 10g |
>99% |
[53123-88-9] |
| R-6712 |
Resiniferatoxin
À̸í : [RTX]
ºÐÀÚ·® : 628.71; ºÐÀÚ½Ä : C37H40O9
¿ëÇØµµ :Soluble in DMSO or ethanol. ÁÖÀÇ:Highly irritant to skin and mucous membranes. SPECIAL HAZARD: TUMOR PROMOTER. Gloves and mask should be worn when using this compound. Care must be taken to prevent contact through all routes of exposure. |
>1 mg, 5mg, 10mg, 25mg, |
>99% |
[57444-62-9] |
| R-7040 |
Ridaforolimus
À̸í :[9CI] [AP 23573] [Deforolimus] [MK-8669]
ºÐÀÚ·® : ; 990.21 ºÐÀÚ½Ä : C53H84NO14P
¿ëÇØµµ : Soluble in DMSO. |
5mg, 10mg, 25mg, 50mg, 200mg, 1g |
>99% |
[572924-54-0] |
| R-8765 |
Resiniferonol 9,13,14-Orthophenylacetate
À̸í : [ROPA]
ºÐÀÚ·® : 464.55 ; ºÐÀÚ½Ä : C28H32O6
¿ëÇØµµ :Soluble in DMSO or ethanol. ÁÖÀÇ:Highly irritant to skin and mucous membranes. SPECIAL HAZARD: TUMOR PROMOTER. Gloves and mask should be worn when using this compound. Care must be taken to prevent contact through all routes of exposure. |
1 mg, 5mg, 10mg, 25mg, 100mg |
>99% |
[57852-42-3] |
| S-1700 |
SB 202190, Free Base
À̸í : [FHPI] [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole]
ºÐÀÚ·® : 331.34 ; ºÐÀÚ½Ä : C20H14FN3O
¿ëÇØµµ :Soluble in DMSO. |
10mg, 25mg, 50mg, 100mg, 200mg, 500mg, 1g |
>99% |
[152121-30-7] |
| S-3400 |
SB 203580, Free Base
À̸í : [4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole]
ºÐÀÚ·® : 377.43 ; ºÐÀÚ½Ä : C21H16FN3OS
¿ëÇØµµ :Soluble in DMSO. |
25mg, 50mg, 100mg, 200mg, 300mg, 500mg, 1g, |
>99% |
[152121-47-6] |
| S-7979 |
SP600125
À̸í : [Anthra(1,9-cd)pyrazol-6(2H)-one] [1,9-Pyrazoloanthrone] [Anthrapyrazolone] [JNK Inhibitor II] [SAPK Inhibitor II]
ºÐÀÚ·® : 220.23; ºÐÀÚ½Ä : C14H8N2O
¿ëÇØµµ :Prepare initial stock solutions in DMSO (soluble at 65 mg/mL) for in vitro use; solubility in ethanol or water is low. |
300mg, 1g, 2g, 5g |
>99% |
[129-56-6] |
| S-8502 |
Sorafenib, p-Toluenesulfonate Salt
À̸í : [Sorafenib Tosylate] [Bay 43-9006] [Nexavar]
ºÐÀÚ·® : 637.03 ; ºÐÀÚ½Ä : C21H16ClF3N4O3.C7H8O3S
¿ëÇØµµ :Very soluble in DMSO, up to about 200 mg/mL; very poorly soluble in water or ethanol. |
300mg, >500mg, 1g, 2g, 5g, 10g, 25g |
>99% |
[475207-59-1] |
| S-8599 |
Sorafenib, Free Base
À̸í : [Bay 43-9006] [Nexavar]
ºÐÀÚ·® : 464.82 ; ºÐÀÚ½Ä : C21H16ClF3N4O3
¿ëÇØµµ :Soluble in DMSO at 200 mg/mL; soluble in ethanol at 3.3 mg/mL with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-50 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
300mg, 500mg, 1g, 2g, 5g, 10g, 25g |
>99% |
[284461-73-0] |
| S-8803 |
Sunitinib, Malate Salt
À̸í : [Sunitinib Maleate] [SU-11248] [Sutent] [PHA-290940AD] [PNU-290940AD]
ºÐÀÚ·® : 532.56 ; ºÐÀÚ½Ä : C22H27FN4O2.C4H6O5
¿ëÇØµµ :Soluble in DMSO at 40 mg/mL; very poorly soluble in ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-50 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
300mg, 500mg , 1g, 2g, 5g, 10g, 25g |
>99% |
[341031-54-7] |
| S-8877 |
Sunitinib, Free Base
À̸í : [SU-11248] [Sutent] [PHA-290940AD] [PNU-290940AD]
ºÐÀÚ·® : 398.47 ; ºÐÀÚ½Ä : C22H27FN4O2
¿ëÇØµµ :Soluble in DMSO at 40 mg/mL; soluble in ethanol at 1.4 mg/mL; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-20 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
300mg, 500mg, 1g, 2g, 5g, 10g, 25g |
>99% |
[557795-19-4] |
| S-8906 |
Saracatinib, Free Base
À̸í :[AZD-0530]
ºÐÀÚ·® : ; 542.039 ºÐÀÚ½Ä : C27H32ClN5O5P
¿ëÇØµµ : Soluble in DMSO. |
10mg, 25mg, 50mg, 100mg, 200mg, 1g |
>99% |
[379231-04-6] |
| S-9300 |
Staurosporine, Free Base
À̸í : [Antibiotic AM-2282]
ºÐÀÚ·® : 466.53 ; ºÐÀÚ½Ä : C28H26N4O3
¿ëÇØµµ :Soluble in DMSO or ethanol; insoluble in water. |
1 mg, 5mg, 10mg, 25mg, 100mg, 300mg |
>99% |
[62996-74-1] |
| S-9344 |
Stauprimide
À̸í :[N-Benzoyl-7-oxostaurosporine]
ºÐÀÚ·® : ; 584.62 ºÐÀÚ½Ä : C35H28N4O5
¿ëÇØµµ : Soluble in DMSO at 100 mg/mL; very poorly soluble in ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 1-10 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
1mg, 5mg, 10mg, 25mg, 50mg, 100mg |
>99% |
[154589-96-5] |
| T-1377 |
Tasocitinib, Free Base
À̸í :[CP-690550]
ºÐÀÚ·® : ; 312.37 ºÐÀÚ½Ä : C16H20N6O
¿ëÇØµµ : Soluble in DMSO. |
10mg, 25mg, 50mg, 100mg, 200mg, 1g |
>99% |
[477600-75-2] |
| T-2304 |
Tozasertib, Free Base
À̸í : [VX-680] [MK-0457] [VX6]
ºÐÀÚ·® : 464.59 ; ºÐÀÚ½Ä : C23H28N8OS
¿ëÇØµµ :Soluble in DMSO. |
10mg, 25mg, 50mg, 100mg, 200mg, 300mg, 500mg, 1g, 2g |
>99% |
[639089-54-6] |
| T-3250 |
Thapsigargin
ºÐÀÚ·® : 650.75 ; ºÐÀÚ½Ä : C34H50O12
¿ëÇØµµ :Soluble in DMSO or ethanol. ÁÖÀÇ:Highly irritant to skin and mucous membranes. SPECIAL HAZARD: TUMOR PROMOTER. Gloves and mask should be worn when using this compound. Care must be taken to prevent contact through all routes of exposure. |
1 mg, 5mg, 10mg, 25mg |
>99% |
[67526-95-8] |
| T-5096 |
Tinyatoxin
À̸í : [TNX] [TYX]
ºÐÀÚ·® : 598.68 ; ºÐÀÚ½Ä : C36H38O8
¿ëÇØµµ :Soluble in DMSO or ethanol. |
1 mg, 5mg |
>99% |
[58821-95-7] |
| T-7310 |
Tyrphostin AG 1478, Free Base
À̸í : [AG 1478]
ºÐÀÚ·® : 315.75 ; ºÐÀÚ½Ä : C16H14ClN3O2
¿ëÇØµµ :Soluble in DMSO, to about 60 mg/ml; poorly soluble in ethanol. |
25mg, 100mg, 500mg, 1g |
>99% |
[175178-82-2] |
| T-7802 |
Tandutinib, Free Base
À̸í : [MLN518] [CT53518]
ºÐÀÚ·® : 562.70 ºÐÀÚ½Ä : C31H42N6O4
¿ëÇØµµ :Soluble in DMSO at 25 mg/mL with warming; soluble in ethanol at 25 mg/mL with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 50-100 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
25mg, 50mg, 100mg, 200mg, 500mg, 1g |
>99% |
[387867-13-2] |
| T-8040 |
Temsirolimus
À̸í : [CCI-779] [Torisel]
ºÐÀÚ·® : 1030.29; ºÐÀÚ½Ä : C56H87NO16
¿ëÇØµµ :Soluble in DMSO at 200 mg/mL; soluble in ethanol at 200 mg/mL; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-20 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
25mg, 50mg, 100mg, 200mg, 300mg, 500mg , 1g |
>99% |
[162635-04-3] |
| T-9142 |
Tyrphostin AG 490
À̸í : [AG 490] [Tyrphostin B42] [N-Benzyl-3,4-dihydroxy-benzylidenecyanoacetamide]
ºÐÀÚ·® : 294.30 ; ºÐÀÚ½Ä : C17H14N2O3
¿ëÇØµµ :Soluble in DMSO. |
25mg, 100mg, 300mg, 1g |
>99% |
[134036-52-5] |
| U-6770 |
U0126
À̸í : [1,4-Diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)-butadiene]
ºÐÀÚ·® : 380.49 ; ºÐÀÚ½Ä : C18H16N6S2
¿ëÇØµµ :Soluble in DMSO. |
25mg, 100mg, 300mg, 1g, 2g |
>99% |
[109511-58-2] |
| V-4050 |
Vismodegib, Free Base 
À̸í :[GDC-0449] [HhAntag691]
ºÐÀÚ·® : ; 421.30 ºÐÀÚ½Ä : C19H14Cl2N2O3S
¿ëÇØµµ : Very poorly soluble in DMSO; very poorly soluble in ethanol; soluble in water at 100 mg/mL; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
10mg, 25mg, 50mg, 200mg, 500mg, 1g, |
>99% |
[879085-55-9] |
| V-8303 |
Vatalanib, Dihydrochloride Salt
À̸í : [CGP-79787] [PTK 787] [ZK222584]
ºÐÀÚ·® : 419.73 ; ºÐÀÚ½Ä : C20H15ClN4.2HCl
¿ëÇØµµ :Soluble in water, up to about 100 mg/mL; very poorly soluble in ethanol; slightly soluble in DMSO, up to about 10-20 mg/mL after heating. |
25mg, 100mg, 200mg , 300mg, 500mg , 1g, 2g |
>99% |
[212141-51-0] |
| V-8477 |
Vorinostat
À̸í :
ºÐÀÚ·® : ; ºÐÀÚ½Ä :
¿ëÇØµµ : |
100mg, 250mg, 500mg, 1g, 2g, 5g, 10g |
>99% |
[19545-26-7] |
| V-9077 |
Vargatef, Free Base
À̸í : [BIBF1120]
ºÐÀÚ·® : 539.62 ; ºÐÀÚ½Ä : C31H33N5O4
¿ëÇØµµ :Soluble in DMSO. |
5mg, 10mg, 25mg, 50mg,100mg, 200mg, |
>99% |
[928326-83-4] |
| V-9366 |
VX-702, Free Base
À̸í :
ºÐÀÚ·® : ; ºÐÀÚ½Ä :
¿ëÇØµµ : |
5mg, 10mg, 25mg, 50mg, 100mg, 200mg 1g, |
>99% |
[19545-26-7] |
| V-9402 |
Vandetanib, Free Base
À̸í : [Zactima] [ZD6474]
ºÐÀÚ·® : 475.35 ; ºÐÀÚ½Ä : C22H24BrFN4O2
¿ëÇØµµ :Soluble in DMSO at 30 mg/mL; soluble in ethanol at 10 mg/mL with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-20 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
50mg, 100mg, 200mg, 300mg, 500mg, 1g, 2g |
>99% |
[443913-73-3] |
| W-2990 |
Wortmannin
À̸í : [KY 12420]
ºÐÀÚ·® : 428.43 ; ºÐÀÚ½Ä : C23H24O8
¿ëÇØµµ :Soluble in DMSO or ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-50 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
10mg, 25mg, 50mg, 100mg, 300mg |
>99% |
[19545-26-7] |
| Z-1066 |
ZSTK474, Free Base
ºÐÀÚ·® : 417.41 ; ºÐÀÚ½Ä : C19H21F2N7O2
¿ëÇØµµ :Soluble in DMSO at 20 mg/mL; soluble in ethanol at 2.5 mg/mL with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 1-5 ¥ìM; buffers, serum, or other additives may increase or decrease the aqueous solubility. |
10mg, 50mg, 100mg, 200mg, 300mg, 1g, 2g |
>99% |
[475110-96-4] |
| Z-9040 |
Zotarolimus
À̸í : [ABT-578] [40-Epi-(N1-tetrazolyl)-rapamycin]
ºÐÀÚ·® : 966.21; ºÐÀÚ½Ä : C52H79N5O12
¿ëÇØµµ :Soluble in DMSO. |
5mg, 25mg, 100mg |
>98% |
[221877-54-9] |
|